Anne Carol Goldberg, MD, FACP, Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine, is a co-author of a study published February 27, 2026, in Nature Medicine. The article, titled “Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial,” explores a potential new option for people living with a genetic condition that causes very high cholesterol.
Goldberg co-authors study on obicetrapib in patients with heterozygous familial hypercholesterolemia
View Content